Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Lantern Pharma Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 33 | 25 | −8 |
| Shares | 1.66M | 1.45M | −205.6K (−12.4%) |
| Value | $13.1M | $10.4M | −$2.74M (−20.9%) |
New holders (3)
Institutions that held Lantern Pharma Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CM Management, LLC | 33,765 | $241.0K | 0.20% |
| Renaissance Technologies LLC | 10,700 | $77.0K | 0.00% |
| Simplex Trading, LLC | 809 | $5.00K | 0.00% |
Sold out (11)
Institutions that held Lantern Pharma Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Anson Funds Management LP | 64,999 | $519.0K |
| Lynwood Capital Management Inc. | 50,000 | $399.0K |
| Millennium Management LLC | 48,558 | $387.0K |
| Trexquant Investment LP | 27,970 | $223.0K |
| Two Sigma Advisers, LP | 25,300 | $202.0K |
| Citadel Advisors LLC | 11,095 | $89.0K |
| Jump Financial, LLC | 11,028 | $88.0K |
| Envestnet Asset Management Inc | 10,542 | $84.0K |
| Susquehanna International Group, LLP | 10,439 | $83.0K |
| Bank Julius Baer & Co. Ltd, Zurich | 2,500 | $20.0K |
| Bank of America Corp | 13 | $0 |